| Pfizer’s Bourla: There’s Coronavirus Vaccine Pressure, But It’s Not Political | Derrick Gingery | 08/12/20 | National |
| Pfizer, BioNTech Choose Full Spike Protein for Pivotal Vaccine Test | Frank Vinluan | 07/28/20 | New York |
| Bio Roundup: A Royal IPO, Akili Arrives, Orca Bio Surfaces & More | Frank Vinluan | 06/19/20 | National |
| Moderna Finalizes Plan, Dose for Phase 3 Test of mRNA COVID Vaccine | Frank Vinluan | 06/11/20 | Boston |
| Fauci Foresees “More Than 1 Winner” in Race for COVID-19 Vaccines, Drugs | Sarah de Crescenzo | 06/10/20 | National |
| Bio Roundup: mRNA Vaccine Data, Rise of Rallybio, Roche’s Protein Play & More | Frank Vinluan | 05/22/20 | National |
| Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More | Frank Vinluan | 04/24/20 | National |
| Affinivax Lands $120M to Take MAPS Tech Into New Vaccine Territory | Frank Vinluan | 04/23/20 | Boston |
| GSK and Sanofi Team Up on COVID-19 Vaccine, Aim for Clinic This Year | Frank Vinluan | 04/14/20 | National |
| Pfizer, BioNTech Say mRNA COVID-19 Vaccine Trials May Start This Month | Frank Vinluan | 04/09/20 | National |
| Inovio Begins Experimental COVID-19 Vaccine Tests in Healthy Volunteers | Sarah de Crescenzo | 04/08/20 | National |
| GSK, Vir Team Up in COVID-19 Pact Aiming to Reach the Clinic in Months | Frank Vinluan | 04/06/20 | San Francisco |
| Sanofi Adds mRNA COVID-19 Vaccine Bet Through Translate Bio Alliance | Frank Vinluan | 03/27/20 | Europe |
| Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More | Frank Vinluan | 03/27/20 | National |
| Merck Charts an R&D-Focused Course Starting With a $6.5B Spinoff | Frank Vinluan | 02/05/20 | New York |
| Icosavax Lands $51M to Bring Vaccine for Respiratory Virus to Clinic | Frank Vinluan | 10/03/19 | Seattle |
| Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More | Frank Vinluan | 09/27/19 | National |
| Meissa Scores $30M to Test Vaccine for Dangerous Respiratory Virus | Bernadette Tansey | 09/26/19 | San Francisco |
| Elanco Boosts Vaccine Portfolio With $60M Prevtec Acquisition | Frank Vinluan | 08/01/19 | Indiana |
| Neon’s Early Vaccine Study Is a Peek at Immunotherapy’s Third Wave | Ben Fidler | 07/15/19 | Boston |
| Bio Roundup: Array Bio Acquired, IPO Spree, Sanofi’s Job Cuts & More | Frank Vinluan | 06/21/19 | National |
| Four More Through the IPO Door as Life Science Firms Raise $465M | Frank Vinluan | 06/20/19 | National |
| Bio Roundup: Opioids in Court, IPO Parade, Brain Cancer Bet & More | Frank Vinluan | 05/31/19 | National |
| The Biotech IPO Queue Grows Longer as Five More Companies File | Frank Vinluan | 05/28/19 | National |
| Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More | Frank Vinluan | 02/22/19 | National |
| Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More | Frank Vinluan | 02/01/19 | National |
| Pfizer, GSK to Merge Consumer Health Units, Focus on Prescription Drugs | Ben Fidler | 12/19/18 | National |
| Moderna Raises $604M and Nails Down Biotech’s Biggest IPO Ever | Ben Fidler | 12/06/18 | Boston |
| Elanco IPO Raises $1.5B as the Animal Health Biz Spins Off from Lilly | Frank Vinluan | 09/20/18 | Indiana |
| With BioNTech Deal, Pfizer Becomes Latest to Bet on mRNA Vaccines | Ben Fidler | 08/16/18 | New York |
